CAR-T
54 Employers in 95 locations
54 Employers in 95 locations
Employers working on CAR-T work in 36 other areas
Displaying 1 - 15 of 36 related areas- Cell and Gene Therapy (46)
- Immunotherapy (20)
- Cancer Therapeutics (18)
- T-Cells (12)
- Antibodies (6)
- Autoimmunity (6)
- Cancer (4)
- COVID-19 (4)
- NK cells (4)
- Biologics (3)
- Immuno-oncology (3)
- Immunology (3)
- RNA (3)
- Synthetic Biology (3)
Displaying 1 - 54 of 54 employers
Only three business areas are listed for each employer.Business Area(s)
Description
Aavocyte focuses on developing various T cell immune therapy products to treat ...
Business Area(s)
Description
AbClon was founded in 2010 by a consortium of Korean and Swedish experts in ...
Business Area(s)
Description
Abintus Bio, Inc. is a preclinical stage gene therapy company focused on the ...
Business Area(s)
Description
Developing CAR-T therapies for solid tumors
Business Area(s)
Description
Aleta Biotherapeutics is an immuno-oncology company focused on transforming ...
Business Area(s)
Description
Allogene Therapeutics is a biotechnology company developing allogeneic chimeric ...
Business Area(s)
Description
By using the body’s immune system, Anixa Biosciences, Inc. is taking multiple ...
Business Area(s)
Description
Appia Bio leverages the biology of lymphocyte development with chimeric antigen ...
Business Area(s)
Description
Autolus is at the forefront of a revolution in cancer treatment. Chimeric ...
Business Area(s)
Description
GEMoaB GmbH is a privately-owned, clinical-stage biopharmaceutical company based ...
Business Area(s)
Description
Beam Therapeutics is pioneering the use of CRISPR base editing to develop ...
Business Area(s)
Description
BioNTech was founded in 2008 on the understanding that every cancer patient’s ...
Business Area(s)
Description
Developing chimeric antigen receptor (CAR) T-cell and antibody programs that ...
Business Area(s)
Description
BrainChild Bio is a kids-first, clinical-stage biotechnology company focused on ...
Business Area(s)
Description
A biopharmaceutical company. They discover, develop, and deliver medicines to ...
Business Area(s)
Description
Cabaletta Bio is working to develop specifically targeted CAAR (Chimeric ...
Description
Capstan is combining the power of in vivo cell therapy with the precision of ...
Business Area(s)
Description
CARsgen Therapeutics，a biopharmaceutical company based in Shanghai, with ...
Business Area(s)
Description
Cartesian Therapeutics is a clinical-stage biopharmaceutical company developing ...
Business Area(s)
Description
The company develops immunotherapies for blood and bone marrow cancers by using ...
Business Area(s)
Description
Celularity is a biotechnology company productizing allogeneic cells and tissues ...
Business Area(s)
Description
Celyad Oncology is a clinical-stage biotechnology company focused on the ...
Business Area(s)
Description
Concentra Biosciences is a California-based private company founded in 2023 that ...
Business Area(s)
Description
CREATE Medicines is pioneering multi-immune programming with its versatile in ...
Business Area(s)
Description
CytoImmune Therapeutics is a clinical-stage biotechnology company developing ...
Business Area(s)
Description
Cytovia aims to accelerate patient access to transformational cell therapies and ...
Business Area(s)
Description
Dragonfly makes proprietary TriNKETs (Tri-specific, NK cell Engager Therapies) ...
Business Area(s)
Description
EXUMA Biotech is a clinical-stage biotechnology company discovering and ...
Business Area(s)
Description
Fate Therapeutics is a clinical-stage biopharmaceutical company working on a ...
Business Area(s)
Description
Gracell is developing cell and gene therapies for cancer patients
Business Area(s)
Description
IASO Bio is a clinical-stage biopharmaceutical company engaged in the discovery ...
Business Area(s)
Description
The company is developing immunotherapies that use microorganisms to deliver ...
Business Area(s)
Description
Interius BioTherapeutics is an early-stage biotechnology company expanding the ...
Business Area(s)
Description
Kite, a Gilead company, produces personalized cell therapies for treating cancer ...
Business Area(s)
Description
Kyverna Therapeutics is navigating what’s next in synthetic biology, immunology ...
Business Area(s)
Description
Leah Laboratories is adpating cell therapies, approved in humans, for pets.
Business Area(s)
Description
Legend Biotech's first product candidate, LCAR-B38M, is a B cell maturation ...
Business Area(s)
Description
On a mission is to develop CAR-T therapies
Business Area(s)
Description
A CAR-T cell therapy company.
Business Area(s)
Description
Lyell's goal is to develop curative cell-based immunotherapies for any cancer ...
Business Area(s)
Description
Mustang Bio, Inc., a subsidiary of Fortress Biotech, Inc., is a clinical‐stage ...
Business Area(s)
Description
Noile-Immune Biotech is a clinical stage biotechnology company focused on the ...
Business Area(s)
Description
Orna Therapeutics is a biotechnology company dedicated to designing and ...
Business Area(s)
Description
Using CAR-T for cancer therapies and gene editing for other diseases.
Business Area(s)
Description
Cancer drugs
Business Area(s)
Description
Proteins, iPS Cells, Kits, etc, customized antibodies, cell lines
Business Area(s)
Description
Shenzhen Pregene Biopharma Co., Ltd. (Pregene) is a Chinese biotechnology ...
Business Area(s)
Description
Developing IPS Cell therapies that evade the immune system. Their Katana ...
Business Area(s)
Description
Sonoma Biotherapeutics, is a privately held company developing regulatory T cell ...
Business Area(s)
Description
Solid tumor immunotherapies fail because of antigen heterogeneity, antigen ...
Business Area(s)
Description
Verismo is working on CAR-T therapy for solid tumors.
Business Area(s)
Description
Wugen is developing off-the-shelf cellular therapies for cancer. Their NK cell ...
Business Area(s)
Description
Xenetic Biosciences is a biopharmaceutical company focused on advancing XCART™ ...
Business Area(s)
Description
Xyphos is an Astellas company. Their CAR-T technology exploits a powerful immune ...